In vitro studies of antibacterial and antifungal wound dressings comprising H2TiO3 and SiO2 nanoparticles

• Autorzy: Krokowicz L. , Tomczak H. , Bobkiewicz A. , Mackiewicz J. , Marciniak R. , Drews M. , Banasiewicz T.
• Języki publikacji: EN

Abstrakty

EN

The incidence rate of the infected and complex wound is established at approximately 40 000/1 million of the world’s adult population. The aim of this study was to assess the efficiency of three novel types of wound dressings comprising sodium chloride, metatitanic acid and silicon dioxide nanoparticles. The study design was to prove their antimicrobial properties against the microorganisms most commonly causing wound infections. The study evaluated the antimicrobial effect of tested dressings on referenced strains of bacteria (ATCC collection, Argenta, Poland) and strains of fungi species (our own collection of fungi cultured from patients). The dressings were tested with both bacterial and fungal strains on solid media (Mueller-Hinton, Sobouraud, bioMerieux, France) in the standard method. The results confirmed the inhibition of growth of bacteria and revealed zones of inhibition for Escherichia coli, Staphylococcus aureus and Enterococcus faecalis. Significant zones of inhibition were established for Staphylococcus aureus and for fungi species of the Candida sp. These results would be crucial due to the fact of the low availability of antifungal therapeutics for both systemic and topical usage. Moreover, the current standard of antifungal treatment is associated with high costs and high toxicity in general. The preliminary results are very promising but further studies are necessary. Based on the obtained results, the tested dressings may contribute to the development of the surgical armamentarium of complex wound management in the near future.

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2015
• Tom: 64
• Numer: 2
• Opis fizyczny: p.137-142,fig.,ref.

Twórcy

autor

Krokowicz L.

• Department of General Surgery, Oncologic Gastroenterologic Surgery and Plastic Surgery, Poznan University of Medical Sciences, Poznan, Poland

autor

Tomczak H.

• Central Laboratory of Microbiology, H. Swiecicki Hospital of Poznan University of Medical Sciences, Poznan, Poland

autor

Bobkiewicz A.

• Department of General Surgery, Oncologic Gastroenterologic Surgery and Plastic Surgery, Poznan University of Medical Sciences, Poznan, Poland

autor

Mackiewicz J.

• Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland
• Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland
• Department of Medical Oncology, Malgorzata Medical Center, Srem, Poland

autor

Marciniak R.

• Department of General Surgery, Oncologic Gastroenterologic Surgery and Plastic Surgery, Poznan University of Medical Sciences, Poznan, Poland

autor

Drews M.

• Department of General Surgery, Oncologic Gastroenterologic Surgery and Plastic Surgery, Poznan University of Medical Sciences, Poznan, Poland

autor

Banasiewicz T.

• Department of General Surgery, Oncologic Gastroenterologic Surgery and Plastic Surgery, Poznan University of Medical Sciences, Poznan, Poland

Bibliografia

• Baghriche O., S. Rtimi, C. Pulgarin, R. Sanjines and J. Kiwi. 2012. Innovative TiO2/Cu nanosurfaces inactivating bacteria in the minute range under low-intensity actinic light. ACS Appl. Mater Interfaces. 4: 5234–5240.
• Bai H., Z. Liu and D.D. Sun. 2012. Hierarchical nitrogen-doped flowerlike ZnO nanostructure and its multifunctional environmental applications. Chem. Asian J. 7: 1772–1780.
• Charpentier P.A., K. Burgess, L. Wang, R.R. Chowdhury, A.F. Lotus and G. Moula. 2012. Nano-TiO2/polyurethane composites for antibacterial and self-cleaning coatings. Nanotechnology 23: 425606.
• Chu Z., Y. Huang, L. Li, Q. Tao and Q. Li. 2012. Physiological pathway of human cell damage induced by genotoxic crystalline silica nanoparticles. Biomaterials 33: 7540–7546.
• Chu Z., Y. Huang, Q. Tao and Q. Li. 2011. Cellular uptake, evolution, and excretion of silica nanoparticles in human cells. Nanoscale 3: 3291–3299.
• Cooper R. and O. Okhiria. 2006. Biofilms, wound infection and the issue of control. Wounds 2: 48–57.
• Davis S.C., L.Martinez and R. Kirsner. 2006. The diabetic foot: the importance of biofilms and wound bed preparation. Curr. Diab. Rep. 6: 439–445.
• De Jong W.H. and P.J. Borm. 2008. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed 3: 133–149.
• Dzierżanowska D. 2008. Hospital Infections edited by Danuta Dzierżanowska (In Polish). Alfa Medica Press Bielsko-Biała, 2nd ed: 298–305.
• Fadeel B. and A.E. Garcia-Bennett. 2010. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev. 62: 362–374.
• Gottrup F., J. Apelqvist and P. Price. 2010. European Wound Management Association Patient Outcome Group. Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management. J. Wound Care 19: 237–268.
• Kim P.J. and J.S. Steinberg. 2012. Wound care: biofilm and its impact on the latest treatment modalities for ulcerations of the diabetic foot. Semin. Vasc. Surg. 25: 70–74.
• Kostenko V., J. Lyczak, K. Turner and R.J. Martinuzzi. 2010. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob. Agents Chemother. 54: 5120–5131.
• Kowalska-Krochmal B. 2012. Current treatment options for severe infections with antibiotics (In Polish). Forum zakażeń 3: 131–137 Evereth Publishing 2012.
• Moghimi S.M., A.C. Hunter. and J.C. Murray. 2005. Nanomedicine: current status and future prospects. FASEB J. 19: 311–330.
• Pelka R. 1997. The economic situation of chronic wounds. Krankenpfl J. 35: 338.
• Percival S.L. and P. Bowler. 2004. Understanding the effects of bacterial communities and biofilms on wound healing. http://www.worldwidewounds.com, 2013.08.06.
• Percival S.L., K.E. Hill, D.W. Williams, S.J. Hooper, D.W. Thomas and J.W. Costerton. 2012. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 20: 647–657.
• Roguska A., M.Pisarek, M. Andrzejczuk, M. Lewandowska, K.J. Kurzydlowski and M. Janik-Czachor. 2012. Surface characterization of Ca-P/Ag/TiO2 nanotube composite layers on Ti intended for biomedical applications. J. Biomed. Mater. Res. A 100: 1954–1962.
• Saye D.E. 2007. Recurring and antimicrobial-resistant infections: considering the potential role of biofilms in clinical practice. Ostomy Wound Manage 53: 46–52.
• Schweizer M.L. and L.A. Herwaldt. 2012. Surgical site infections and their prevention. Curr. Opin. Infect. Dis. 25: 378–384.
• Sikora A. and M.Kozioł-Montewka. 2010. Surgical site infections: clinical and microbiological aspects (In Polish). Wiadomości Lekarskie 3: 221–229.
• Thomas S. and P. Mccubbin. 2003. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J. Wound Care 12: 101–107.
• Walter C.J., J.C. Dumville, C.A. Sharp and T. Page. 2012. Systematic review and meta-analysis of wound dressings in the prevention of surgical-site infections in surgical wounds healing by primary intention. Br. J. Surg. 99: 1185–1194.
• Wolcott R.D., J.P. Kennedy and S.E. Dowd. 2009. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J. Wound Care 18: 54–56.
• Zabicka D., W. Hryniewicz, R. Izdebski, M. Gniadkowski and A. Kuch. 2009. Recommended selection of the susceptibility tests for bacteria to antibiotics and chemotherapeutics (In Polish). http://www.korld.edu.pl/spec_rekomendacje.php, 2014.04.03.
• Zhukova L.V., J. Kiwi and V.V. Nikandrov. 2012. TiO2 nanoparticles suppress Escherichia coli cell division in the absence of UV irradiation in acidic conditions. Colloids Surf. B. Biointerfaces 1: 240–247.